Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Metagenomi (MGX) Cash from Financing Activities (2023 - 2025)

Metagenomi (MGX) has disclosed Cash from Financing Activities for 3 consecutive years, with $74000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Financing Activities changed N/A to $74000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$356000.0 through Dec 2025, down 100.42% year-over-year, with the annual reading at -$356000.0 for FY2025, 100.42% down from the prior year.
  • Cash from Financing Activities for Q4 2025 was $74000.0 at Metagenomi, up from -$187000.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $86.5 million in Q1 2024, with the low at -$2.0 million in Q2 2024.
  • Average Cash from Financing Activities over 3 years is $7.7 million, with a median of -$166000.0 recorded in 2025.
  • Peak annual rise in Cash from Financing Activities hit 1914.83% in 2024, while the deepest fall reached 5110.26% in 2024.
  • Over 3 years, Cash from Financing Activities stood at -$1.3 million in 2023, then soared by 63.12% to -$492000.0 in 2024, then surged by 115.04% to $74000.0 in 2025.
  • According to Business Quant data, Cash from Financing Activities over the past three periods came in at $74000.0, -$187000.0, and -$166000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.